Tackling 30-day Readmissions in Patients With Cirrhosis: The SALTYFOOD Trial



Status:Recruiting
Conditions:Neurology, Gastrointestinal, Gastrointestinal, Gastrointestinal
Therapuetic Areas:Gastroenterology, Neurology
Healthy:No
Age Range:18 - Any
Updated:7/19/2018
Start Date:April 24, 2018
End Date:April 2021
Contact:Sam Nikirk
Email:samjwalk@med.umich.edu
Phone:734-232-4182

Use our guide to learn which trials are right for you!

The purpose of this study is to determine the feasibility of a home meal delivery program for
patients with cirrhosis and ascites and to determine the effectiveness of a salt-restricted
(2 gram sodium) meal delivery program in reducing the need for therapeutic paracenteses
and/or all-cause re-admissions for these patients. Many patients with cirrhosis don't have
enough nutrients in the body and are frail and these meals may help them maintain a good diet
and lead to improved quality of life.


Inclusion Criteria:

- Adult 18 years or older of age

- Clinical diagnosis of cirrhosis with ascites. Diagnosis of cirrhosis will be based
upon:

1. liver biopsy, OR

2. history of cirrhosis complication: ascites, variceal bleeding, hepatic
encephalopathy, OR

3. 2 of the following 4 criteria: i. Ultrasound (US), computerized axial tomography
(CT) or Magnetic Resonance Imaging (MRI) imaging findings of cirrhosis (cirrhotic
appearing liver, splenomegaly, varices, ascites) ii. Fibroscan liver stiffness
score >13 kPa iii. Laboratory testing: Aspartate Aminotransferase (AST)/platelet
ratio index (APRI) >2.0 iv. CT, MRI or Esophagogastroduodenoscopy (EGD) showing
presence of esophageal varices

- 3) At least one of the following: Any cause hospitalization within 90 days OR
outpatient therapeutic paracentesis within 30 days

Exclusion Criteria:

- Language barriers that cannot be surmounted with in-person interpreters

- Estimated life expectancy < 3 months

- Pregnancy (self-reported)

- Unable or unwilling to provide consent

- History of liver transplant

- Planned discharge to nursing facility

- Anuria or serum creatinine > 2.0 mg/dL

- Diabetes Mellitus

- Uncontrolled hepatic encephalopathy
We found this trial at
1
site
500 S State St
Ann Arbor, Michigan 48109
(734) 764-1817
Phone: 734-232-4182
University of Michigan The University of Michigan was founded in 1817 as one of the...
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials